HIV/AIDS Cancer
In age of HAART, HIV status no longer affects NSCLC mortality risk
Published in AIDS Weekly, September 29th, 2003
Researchers in England conducted a study "to assess the impact of HIV status on the outcome of patients with non-small-cell lung cancer (NSCLC) in the era of highly active antiretroviral therapy (HAART)."
"Patients diagnosed with HIV-related NSCLC in the HAART era (since January 1996) were identified from a prospective single-center lung cancer database," explained T. Powles and coauthors at Chelsea and Westminster Hospital in London. "The clinicopathological characteristics and outcome of each HIV-positive patient were compared to three...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-09-29)
More Articles from AIDS Weekly
- HIV/AIDS Dementia
Novel CXCR4 antagonist may prevent HIV-induced neurotoxicity - HIV/AIDS Therapy
Lopinavir-ritonavir regimens reduce methadone efficacy - HIV/AIDS Therapy
Baseline immune markers do not predict discordant antiretroviral treatment responses - HIV/AIDS Therapy
Drug levels in untimed plasma samples predict treatment outcome in advanced HIV patients - Immunology
CD44 mediates CCL5-induced cell activation and HIV infectivity enhancement - Opportunistic Infection
Bartonella infection common in advanced HIV infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
